Dr William Schaffner discusses strategies clinicians can use to address vaccine hesitancy, fatigue, and misinformation.

Researchers evaluated the immunogenicity of the MenACWY-TT vaccine against hypervirulent serogroup Y meningococcal strains in ...

Researchers conducted a network meta-analysis to compare the efficacy of various oral antibiotic monotherapies for ...

Researchers evaluated household contact transmission risks and vaccination timing among children younger than 5 years.

Research presented at CHEST 2026 highlights the role of rapid antimicrobial testing and antibiotic stewardship in patients ...

Researchers evaluated the association between maternal COVID-19 infection during pregnancy and subsequent neurologic ...

Investigators evaluated HPV vaccine initiation at ages 9 to 10 years vs 11 to 12 years across pediatric practices in Colorado ...

Long COVID rates are elevated in patients with autoimmune rheumatic conditions, highlighting the need for targeted clinical monitoring. HealthDay News — Patients with autoimmune rheumatic diseases ...

Infectious disease experts Paul E Sax, MD and Cynthia L Sears, MD shared their thoughts on the most compelling trends and studies in infectious diseases at IDWeek 2026, held from October 21 to 24, in ...

Older adults exhibited a decreased risk for severe respiratory syncytial virus outcomes following administration of either RSVPreF3+AS01 or RSVpreF during the 2023 to 2024 season. Two respiratory ...

Adult patients who receive the RSVpreF vaccine do not experience a higher incidence of myocarditis or pericarditis compared with unvaccinated individuals. The respiratory syncytial virus (RSV) ...

Influenza remains the leading cause of vaccine-preventable death in US children, emphasizing the need to strengthen pediatric immunizations, expand access, and maintain surveillance. Influenza-related ...